Our top pick for
Finder may earn compensation from partners, but editorial opinions are our own. Advertiser Disclosure
Pulse Biosciences Inc is a medical instruments & supplies business based in the US. Pulse Biosciences shares (PLSE) are listed on the NASDAQ and all prices are listed in US Dollars. Pulse Biosciences employs 95 staff and has a market cap (total outstanding shares value) of 0.00.
|Latest market close||$21.63|
|52-week range||$11.60 - $45.82|
|50-day moving average||$21.56|
|200-day moving average||$20.34|
|Wall St. target price||$38.00|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$-2.35|
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
|1 week (2021-10-20)||-1.73%|
|1 month (2021-09-27)||-3.82%|
|3 months (2021-07-27)||5.56%|
|6 months (2021-04-27)||3.00%|
|1 year (2020-10-26)||68.72%|
|2 years (2019-10-25)||44.68%|
|3 years (2018-10-26)||98.81%|
|5 years (2016-10-26)||271.01%|
|Gross profit TTM||$0|
|Return on assets TTM||-54.18%|
|Return on equity TTM||-118.75%|
|Market capitalisation||$659.6 million|
TTM: trailing 12 months
There are currently 1.5 million Pulse Biosciences shares held short by investors – that's known as Pulse Biosciences's "short interest". This figure is 6.6% down from 1.6 million last month.
There are a few different ways that this level of interest in shorting Pulse Biosciences shares can be evaluated.
Pulse Biosciences's "short interest ratio" (SIR) is the quantity of Pulse Biosciences shares currently shorted divided by the average quantity of Pulse Biosciences shares traded daily (recently around 62472.890025575). Pulse Biosciences's SIR currently stands at 23.46. In other words for every 100,000 Pulse Biosciences shares traded daily on the market, roughly 23460 shares are currently held short.
However Pulse Biosciences's short interest can also be evaluated against the total number of Pulse Biosciences shares, or, against the total number of tradable Pulse Biosciences shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Pulse Biosciences's short interest could be expressed as 0.05% of the outstanding shares (for every 100,000 Pulse Biosciences shares in existence, roughly 50 shares are currently held short) or 0.0862% of the tradable shares (for every 100,000 tradable Pulse Biosciences shares, roughly 86 shares are currently held short).
A SIR above 20% would generally be considered very high, pointing to a pessimistic outlook for the share price, with a discouraging number of investors currently willing to bet against Pulse Biosciences.
Find out more about how you can short Pulse Biosciences stock.
We're not expecting Pulse Biosciences to pay a dividend over the next 12 months.
Over the last 12 months, Pulse Biosciences's shares have ranged in value from as little as $11.6 up to $45.82. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Pulse Biosciences's is 1.7217. This would suggest that Pulse Biosciences's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. It offers CellFX System, a tunable, software-enabled, and console-based platform that delivers nano second duration pulses of electrical energy to non-thermally clear targeted cells while sparing adjacent non-cellular tissue primarily for dermatology applications by using its Nano-Pulse Stimulation technology. The company was formerly known as Electroblate, Inc. and changed its name to Pulse Biosciences, Inc. in December 2015. Pulse Biosciences, Inc.
See the 10 biggest gainers on the New York Stock Exchange and Nasdaq on Oct. 22, 2021
Everything we know about the Trump Media and Technology Group IPO, plus information on how to buy in.
Steps to owning and managing Valkyrie Bitcoin Strategy ETF units.
See the 10 biggest gainers on the New York Stock Exchange and Nasdaq on Oct. 21, 2021
Steps to owning and managing ProShares Bitcoin Strategy ETF units.
Everything we know about the The Real Good Food Company IPO, plus information on how to buy in.
Everything we know about the Lulu’s Fashion Lounge Holdings IPO, plus information on how to buy in.
Everything we know about the Allarity Therapeutics IPO, plus information on how to buy in.
Everything we know about the Jupiter Neurosciences IPO, plus information on how to buy in.
Everything we know about the Mainz Biomed IPO, plus information on how to buy in.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.